relative to increasing transparency in the 340B Drug Pricing Program.

SB 477 requires hospitals and other 340B-covered entities in New Hampshire to submit annual public reports to the Department of Health and Human Services by April 1. These reports must detail patient usage of 340B drugs (by insurance type), financial data including acquisition costs and reimbursements for drugs and other services, net revenue, and charity care costs. The bill mandates separate reporting for hospitals, their practice locations, and contracted pharmacies, along with CEO/CFO attestations confirming accuracy. It aims to increase transparency by making 340B program financial data publicly available and preventing duplicate discounts.